Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Genichi Sugihara

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 30, 2008
Methamphetamine causes microglial activation in the brains of human abusersYoshimoto Sekine, Yasuomi Ouchi, Genichi Sugihara, et al.
Plos One|May 30, 2008
Irradiation in adulthood as a new model of schizophreniaYasuhide Iwata, Katsuaki Suzuki, Tomoyasu Wakuda, et al.
Neuroscience Research|November 23, 2006
Linkage disequilibrium analysis of the CHRNA7 gene and its partially duplicated region in schizophreniaYasuhide Iwata, Mizuho Nakajima, Kazuo Yamada, et al.
Psychiatry and Clinical Neurosciences|November 23, 2020
Novel brief screening scale, Tokyo Metropolitan Distress Scale for Pandemic (TMDP), for assessing mental and social stress of medical personnel in COVID-19 pandemicHiroki Shiwaku, Satomi Doi, Miho Miyajima, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 15, 2010
Failure to confirm genetic association of the FXYD6 gene with schizophrenia: the Japanese population and meta-analysisYasuhide Iwata, Kazuo Yamada, Yoshimi Iwayama, et al.
Journal of Psychiatric Research|March 18, 2021
Factors affecting mental illness and social stress in hospital workers treating COVID-19: Paradoxical distress during pandemic eraYukiko Matsumoto, Junya Fujino, Hiroki Shiwaku, et al.
Psychiatry and Clinical Neurosciences|July 15, 2016
Current viewpoints on DSM-5 in JapanToshihide Kuroki, Makoto Ishitobi, Yoko Kamio, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 26, 2009
Association analyses between brain-expressed fatty-acid binding protein (FABP) genes and schizophrenia and bipolar disorderYoshimi Iwayama, Eiji Hattori, Motoko Maekawa, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 26, 2007
A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcriptionTetsuo Ohnishi, Kazuo Yamada, Hisako Ohba, et al.
Psychiatry and Clinical Neurosciences|October 23, 2025
Effects of Extended-Release Methylphenidate on Dopamine and Norepinephrine Transporters in Adults With Attention-Deficit/Hyperactivity Disorder: A Longitudinal Dual-Tracer PET StudyMasaki Oya, Kiwamu Matsuoka, Manabu Kubota, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 30, 2008
Methamphetamine causes microglial activation in the brains of human abusersYoshimoto Sekine, Yasuomi Ouchi, Genichi Sugihara, et al.
Plos One|May 30, 2008
Irradiation in adulthood as a new model of schizophreniaYasuhide Iwata, Katsuaki Suzuki, Tomoyasu Wakuda, et al.
Neuroscience Research|November 23, 2006
Linkage disequilibrium analysis of the CHRNA7 gene and its partially duplicated region in schizophreniaYasuhide Iwata, Mizuho Nakajima, Kazuo Yamada, et al.
Psychiatry and Clinical Neurosciences|November 23, 2020
Novel brief screening scale, Tokyo Metropolitan Distress Scale for Pandemic (TMDP), for assessing mental and social stress of medical personnel in COVID-19 pandemicHiroki Shiwaku, Satomi Doi, Miho Miyajima, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 15, 2010
Failure to confirm genetic association of the FXYD6 gene with schizophrenia: the Japanese population and meta-analysisYasuhide Iwata, Kazuo Yamada, Yoshimi Iwayama, et al.
Journal of Psychiatric Research|March 18, 2021
Factors affecting mental illness and social stress in hospital workers treating COVID-19: Paradoxical distress during pandemic eraYukiko Matsumoto, Junya Fujino, Hiroki Shiwaku, et al.
Psychiatry and Clinical Neurosciences|July 15, 2016
Current viewpoints on DSM-5 in JapanToshihide Kuroki, Makoto Ishitobi, Yoko Kamio, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 26, 2009
Association analyses between brain-expressed fatty-acid binding protein (FABP) genes and schizophrenia and bipolar disorderYoshimi Iwayama, Eiji Hattori, Motoko Maekawa, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 26, 2007
A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcriptionTetsuo Ohnishi, Kazuo Yamada, Hisako Ohba, et al.
Psychiatry and Clinical Neurosciences|October 23, 2025
Effects of Extended-Release Methylphenidate on Dopamine and Norepinephrine Transporters in Adults With Attention-Deficit/Hyperactivity Disorder: A Longitudinal Dual-Tracer PET StudyMasaki Oya, Kiwamu Matsuoka, Manabu Kubota, et al.
Pageof 13